---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-147674"
form_type: "8-K"
ticker: "NDSN"
cik: "0000072331"
company_name: "NORDSON CORP"
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:26:53.996296+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nordson to acquire Atrion for $460/share in cash, ~$800M enterprise value

## Summary
- Deal price $460/share cash; enterprise value ~$800M; 15x 2024 estimated EBITDA including expected synergies.
- Atrion 2023 revenue ~$169M; key businesses: Halkey Roberts, Atrion Medical, Quest Medical in infusion and cardiovascular.
- Expected close before Nordson fiscal year-end Oct 2024; funded by cash on hand and new debt.
- Three FDA-registered U.S. manufacturing facilities expand Nordson MEDICAL's addressable market.

## SEC filing metadata
- accession: 0001193125-24-147674
- form_type: 8-K
- ticker: NDSN
- cik: 0000072331
- company_name: NORDSON CORP
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72331/000119312524147674/0001193125-24-147674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72331/000119312524147674/d836379d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-147674
- JSON: https://secwatch.observer/filing/0001193125-24-147674.json
- Plain text: https://secwatch.observer/filing/0001193125-24-147674.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.